These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 11495449

  • 1. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
    Wakhlu A, Gaur SP, Kaushal GP, Misra A, Asthana P, Sircar AR.
    Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
    [Abstract] [Full Text] [Related]

  • 2. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S, Hazra SK, Saha B, Mazumder B, Biswas PC, Chattopadhya D, Saha K.
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [Abstract] [Full Text] [Related]

  • 3. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients.
    Kar HK, Sharma AK, Misra RS, Zaheer SA, Mukherjee A, Mukherjee R, Beena KR, Kaur H, Nair SK, Talwar GP.
    Indian J Lepr; 1992 Sep; 64(4):495-500. PubMed ID: 1308525
    [Abstract] [Full Text] [Related]

  • 4. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
    Majumder V, Mukerjee A, Hajra SK, Saha B, Saha K.
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
    [Abstract] [Full Text] [Related]

  • 5. Induction of lepromin positivity and immunoprophylaxis in household contacts of multibacillary leprosy patients: a pilot study with a candidate vaccine, Mycobacterium w.
    Sharma P, Kar HK, Kaur H, Misra RS, Mukherjee A, Mukherjee R, Rani R.
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):136-42. PubMed ID: 11036493
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S, Hajra SK, Mukerjee A, Saha B, Majumdar V, Chattapadhya D, Saha K.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [Abstract] [Full Text] [Related]

  • 7. Effects of ICRC antileprosy vaccine in healthy subjects.
    Chaturvedi RM, Chirmule NB, Yellapurkar MV, Shaikh SU, Deo MG.
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):657-66. PubMed ID: 3323368
    [Abstract] [Full Text] [Related]

  • 8. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD, Anantharaman DS, De Britto RL, Vallishayee RS, Nagaraju B, Kannan S, Sengupta U.
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [Abstract] [Full Text] [Related]

  • 9. Pilot study to determine acceptability and ability of heat-killed Mycobacterium leprae plus BCG (HKML+BCG) vaccine to induce skin test conversion.
    Chen ZL, Tang QG, Wang ZM, Chen J.
    Lepr Rev; 1993 Jun; 64(2):117-27. PubMed ID: 8341114
    [Abstract] [Full Text] [Related]

  • 10. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ, Baskin GB, Xu K, Ratterree MS, Mack PA, Bohm RP, Meyers WM, Walsh GP.
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [Abstract] [Full Text] [Related]

  • 11. Reversal reaction in lepromatous patients induced by a vaccine containing killed ICRC bacilli--a report of five cases.
    Bhatki WS, Chulawala RG, Bapat CV, Deo MG.
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):466-72. PubMed ID: 6368413
    [Abstract] [Full Text] [Related]

  • 12. Prospective immunological follow-up in household contacts of Mexican leprosy patients.
    Amezcua ME, Escobar-Gutiérrez A, Barba-Rubio J, Cázares JV, Mayén E, Chávez-Núñez M, Peña RC, Rodríguez R, Pastén S.
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):651-9. PubMed ID: 2280115
    [Abstract] [Full Text] [Related]

  • 13. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
    Convit J, Aranzazu N, Pinardi M, Ulrich M.
    Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331
    [Abstract] [Full Text] [Related]

  • 14. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
    Sharma P, Mukherjee R, Talwar GP, Sarathchandra KG, Walia R, Parida SK, Pandey RM, Rani R, Kar H, Mukherjee A, Katoch K, Benara SK, Singh T, Singh P.
    Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
    [Abstract] [Full Text] [Related]

  • 15. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD, Vallishayee RS, De Britto LJ, Anantharaman DS.
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
    Bapat CV, Modak MS, DeSouza NG, Chulawalla RG.
    Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
    [Abstract] [Full Text] [Related]

  • 17. Sensitization and reactogenicity of two doses of candidate antileprosy vaccine Mycobacterium w.
    Gupte MD, Vallishayee RS, Anantharaman DS, Britto RL, Nagaraju B.
    Indian J Lepr; 1996 Oct; 68(4):315-24. PubMed ID: 9001899
    [Abstract] [Full Text] [Related]

  • 18. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction.
    Gill HK, Mustafa AS, Godal T.
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799
    [Abstract] [Full Text] [Related]

  • 19. Lymphocyte transformation test in healthy contacts of patients with leprosy. I. Influence of exposure to leprosy within a household.
    Menzel S, Bjune G, Kronvall G.
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):138-52. PubMed ID: 378871
    [Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T, Kaur I, Kumar B, Radotra BD, Dogra S.
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.